Medicine & Therapeutics
Exploring evidence-led approaches to therapeutics, formulation, mechanisms and potential applications.
Discuss a programme →MeGha Research Centre is an emerging Singapore-based research initiative envisioned to advance medicine through scientific collaboration, translational research and responsible innovation.
Our vision is to develop MeGha Research Centre into a collaborative biomedical research platform in Singapore — connecting researchers, universities, healthcare professionals and industry around meaningful scientific questions.
Initial programmes are intended to be developed with qualified scientific partners. Specific research areas will be selected based on evidence, unmet need and collaborative expertise.
Exploring evidence-led approaches to therapeutics, formulation, mechanisms and potential applications.
Discuss a programme →Bridging early scientific findings with practical pathways toward validation, development and future clinical relevance.
Discuss a programme →Studying bioactive compounds and traditional formulations through modern analytical and evidence-based frameworks.
Discuss a programme →Evaluating emerging tools, digital methods and interdisciplinary approaches that can accelerate biomedical discovery.
Discuss a programme →Research themes shown are strategic areas of interest. They do not represent approved medicines, active clinical trials or confirmed institutional collaborations.
High-impact biomedical research is rarely created in isolation. MeGha Research Centre is being conceived around a partnership-first model.
Start a conversation ↗Joint research concepts, academic expertise, laboratory collaboration and knowledge exchange.
Understanding unmet medical needs and supporting responsible translational pathways.
Scientific development, technology partnerships, validation and future commercialisation opportunities.
Building multidisciplinary teams around specific programmes and research questions.
Singapore offers a sophisticated biomedical ecosystem, global connectivity, strong intellectual property protections and close links between academia, healthcare and industry.
A measured pathway allows the organisation to develop credibility, partnerships and research capability before committing to capital-intensive laboratory infrastructure.
Establish the Singapore entity, scientific governance and research priorities.
Develop university, research institute and industry collaborations around selected programmes.
Commission or co-develop research, generate evidence and establish intellectual property pathways.
Expand in-house scientific teams and evaluate dedicated laboratory infrastructure as programmes mature.
We welcome early conversations with researchers, institutions, clinicians, innovators and prospective strategic partners.